Radiopharmaceuticals; Production, Physics and Clinical Applications in Nuclear Medicine. A Review

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 169

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_AJBMS-1-2_008

تاریخ نمایه سازی: 2 مهر 1403

چکیده مقاله:

Introduction Utilization of radioactive atoms is increasing in medicine; both for diagnosis and therapy. Methods in which radioactive atoms are entered (IV, orally or inhale) into the patient body, so radiation emits (not transmit) from body called Nuclear Medicine. Some artificial short-living radioisotopes labeled with special pharmaceuticals can be used in Nuclear Medicine, called radiopharmaceutical or Radio-tracer. Today around ۱۸۰۰ radioisotopes exist, but only about ۲۰۰ radioisotopes are capable to be used on general applications, and most of these radioisotopes are artificially produced. There are four different methods to generate radioisotopes: reactor-producing, neutron activation, charged acceleration and radioisotope generators, but neutron activation has the prominent role (۸۰%) of radioisotope production. Cyclotron as particle accelerator, produces many other radioisotopes for medical application. Physical and biomedical characteristics are two important consideration of radiopharmaceuticals for clinical usage. Physical aspects include type and energy of radiation, mother and daughter radioactive elements, purity, and half-life of radioactive. Biomedical consideration for selection radioactive contain easily adhesion to biomolecules, dynamic time course in the body, toxicity and high tissue targeting. Radiopharmaceuticals used in diagnosis are different from those are used in therapy. For Positron Emission Tomography (PET), radioisotopes are positron emitter. Gamma emitting radioisotope labeled radiopharmaceuticals are suitable for single photon emission computed tomography (SPECT) imaging. For therapeutic utilization, radiotracers must deliver high dose radiation to disease sites; i.e. targeted therapy and targeted drug delivery. Radioisotopes emitting Beta minus are the most common isotopes in therapeutic radiopharmaceuticals. Today, more than ۹۰% of radiopharmaceutical are used for diagnostic purposes.Introduction Utilization of radioactive atoms is increasing in medicine; both for diagnosis and therapy. Methods in which radioactive atoms are entered (IV, orally or inhale) into the patient body, so radiation emits (not transmit) from body called Nuclear Medicine. Some artificial short-living radioisotopes labeled with special pharmaceuticals can be used in Nuclear Medicine, called radiopharmaceutical or Radio-tracer. Today around ۱۸۰۰ radioisotopes exist, but only about ۲۰۰ radioisotopes are capable to be used on general applications, and most of these radioisotopes are artificially produced. There are four different methods to generate radioisotopes: reactor-producing, neutron activation, charged acceleration and radioisotope generators, but neutron activation has the prominent role (۸۰%) of radioisotope production. Cyclotron as particle accelerator, produces many other radioisotopes for medical application. Physical and biomedical characteristics are two important consideration of radiopharmaceuticals for clinical usage. Physical aspects include type and energy of radiation, mother and daughter radioactive elements, purity, and half-life of radioactive. Biomedical consideration for selection radioactive contain easily adhesion to biomolecules, dynamic time course in the body, toxicity and high tissue targeting. Radiopharmaceuticals used in diagnosis are different from those are used in therapy. For Positron Emission Tomography (PET), radioisotopes are positron emitter. Gamma emitting radioisotope labeled radiopharmaceuticals are suitable for single photon emission computed tomography (SPECT) imaging. For therapeutic utilization, radiotracers must deliver high dose radiation to disease sites; i.e. targeted therapy and targeted drug delivery. Radioisotopes emitting Beta minus are the most common isotopes in therapeutic radiopharmaceuticals. Today, more than ۹۰% of radiopharmaceutical are used for diagnostic purposes.

نویسندگان

Sayed Mahdi Mutahari

Radiology Department, Kabul University of Medical Sciences, Kabul, Afghanistan

Fatemah Alemzada

Jamal Alshifa Medical Institute, Kabul, Afghanistan